S.A. Johnson

机构：University of Colorado Denver · ORCID：0000-0003-2180-9223

发表论文 46 篇 · 总被引 2597 次 · h-index 22

代表论文

• Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia (1996 · The Lancet · 被引 441)
• Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis (2009 · British Journal of Haematology · 被引 278)
• Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. (1995 · The Journal of Experimental Medicine · 被引 263)
• Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases (1995 · The Journal of Immunology · 被引 228)
• Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenström Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma (2012 · Journal of Clinical Oncology · 被引 154)
• Analysis of Ig‐alpha‐tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig‐alpha stimulation of Fyn activity. (1994 · The EMBO Journal · 被引 133)